Hepatitis C virus RNA in anti-HCV positive hemodialyzed patients: Significance and therapeutic implications

Kidney International

Volumn 44, Issue 5, 1993, Pages 1097-1100

  Pol, Stanislas ^a   Romeo, Raffaella ^b   Zins, Brigitte ^b   Driss, Françoise ^b   Lebkiri, Bernard ^b   Carnot, Françoise ^b   Berthelot, Pierre ^b   Bréchot, Christian ^b  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; ANTIVIRUS AGENT; VIRUS RNA;

ADULT; ARTICLE; FEMALE; HEMODIALYSIS; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VIRUS INFECTION;

BASE SEQUENCE; BIOPSY; CHRONIC DISEASE; FEMALE; HEPACIVIRUS; HEPATITIS ANTIBODIES; HUMAN; LIVER; LIVER DISEASES; MALE; MIDDLE AGE; MOLECULAR PROBES; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; RENAL DIALYSIS; RNA, VIRAL; VIREMIA;

EID: 0027504601     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1993.354     Document Type: Article

References (22)

1. DEBURE A, DEGOS F, POL S, DEGOTT C, CARNOT F, LUGASSY C, LACOMBE M, KREIS H: Liver diseases and hepatic complications in renal transplant patients. Adv Nephrol 17:375-400, 1988
2. ELISAF M, TSIANOS E, MAVRIDIS A, DARDAMANIS M, PAPPAS M, SIAMOPOULOS KC: Antibodies against hepatitis C virus (anti-HCV) in haemodialysis patients: Association with hepatitis B serological markers. Nephrol Dial Transplant 6:476-479, 1991
3. MONDELLI MU, SMEDILE V, PIAZZA V, VILLA G, BARBIERI C, GATTARELLO G, MANCINI F, RAIMONDO G: Abnormal alanine aminotransferase activity reflects exposure to hepatitis C virus in haemodialysis patients. Nephrol Dial Transplant 6:480-483, 1991
4. SCHLIPKOTER U, ROGGENDORF M, ERNST G, RASSHOFER R, DEINHARDT F, WEISE A, GLADZIWA U, LUZ N: Hepatitis C virus antibodies in haemodialysis patients. (letter) Lancet 335:1409, 1992
5. POL S, LEGENDRE C, SALTIEL C, CARNOT F, BRÉCHOT C, BERTHELOT P, MATTLINGER B, KREIS H: Hepatitis C virus in kidney recipients. Epidemiology and impact on renal transplantation. J Hepatol 15:202-206, 1992
6. JANOT C, COUROUCÉ AM, MANIEZ M: Antibodies to hepatitis C virus in French blood donors, (letter) Lancet 2:294-297, 1989
7. KALLINOWSKI B, THEILMANN L, GMELIN K, RAMBAUSEK M, MOHRING M, KOMMERELL B: Incidence and prevalence of antibodies to hepatitis C virus in kidney transplant patients. J Hepatol 12:404-405, 1991
8. MULLER GY, ZABALETA ME, ARMINIO A, COLMENARES CJ, CAPRILES FI, BIANCO NE, MACHADO IV: Risk factors for dialysis-associated hepatitis C in Venezuela. Kidney Int 41:1055-1058, 1992
9. CHAN TM, LOK ASF, CHENG IKP, CHAN RT: Prevalence of hepatitis C virus infection in hemodialysis patients: A longitudinal study comparing the results of RNA and antibody assays. Hepatology 17:5-8, 1993
10. CHAN TM, LOK ASF, CHENG IKP, CHAN RT: A prospective study of hepatitis C virus infection among renal transplant recipients. Gastroenterology 104:862-868, 1993
11. POL S, DEBURE A, DEGOTT C, CARNOT F, LEGENDRE C, BRÉCHOT C, KREIS H: Chronic hepatitis in kidney allograft recipients. Lancet 335:878-880, 1990
12. DEGOTT C, DEGOS F, JUNGERS P, NARET C, COUROUCE AM, POTET F, CROSNIER J: Relationship between liver histopathological changes and HBsAg in 111 patients treated by long-term hemodialysis. Liver 3:377-384, 1983
13. FERAY C, SAMUEL D, THIERS V, GIGOU M, PICHON F, BISMUTH A, REYNES M, MAISONNEUVE P, BRECHOT C: Reinfection of liver graft by hepatitis C virus (HCV) after liver transplantation. J Clin Invest 89:1361-1365, 1992
14. NALPAS B, THIERS V, POL S, DRISS F, THÉPOT V, BERTHELOT P, BRÉCHOT C: Hepatitis C viremia and anti-HCV antibodies in alcoholics. J Hepatol 14:381-384, 1992
15. OKAMOTO H, OKADA S, SUGIYAMA M, YOTSUMOTO S, TANAKA T, YOSHIZAWADA H, TSUDA F, MIYAKAWA Y, MAYUMI M: The 5′ terminal sequence of hepatitis C virus genome. Jpn J Exp Med 60:167-177, 1990
16. SCHEUER PJ: Classification of chronic viral hepatitis: A need for reassessment. J Hepatol 13:372-374, 1991
17. ALTER HJ, PURCELL R, SHIH JW, MELPOLDER JC, HOUGHTON M, CHOO Q-L, KUO G: Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A,non-B hepatitis. N Engl J Med 321:1494-1500, 1989
18. KRUZ P, KOHLER H, MEUER SC, HÜTTEROTH T, MEYER ZUM BÜSCHENFELDE K-H: Impaired cellular immune responses in chronic renal failure. Evidence for a T cell defect. Kidney Int 29:1209-1214, 1986
19. ALBERTI A, MORSICA G, CHEMELLO L, CAVALLETTO D, NOVENTA F, PONTISSO P, RUOL A: Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV. Lancet 340:697-698, 1992
20. DAVIS GL: Interferon treatment of viral hepatitis in immunocompromised patients. Semin Liver Dis 9:267-272, 1989
21. DONAHUE JG, MUNOZ A, NESS PM, BROWN DE, YAWN DH, MCALLISTER HA, REITZ BA, NELSON KE: The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 327:369-373, 1992
22. MARCHESI D, ARICI C, POLETTI E, MINGARDI G, MINOLA E, MECCA G: Outbreak of Non-A, Non-B hepatitis in centre haemodialysis patients: A retrospective analysis. Nephrol Dial Transplant 3:795-799, 1988